Bladder Cancer Clinical Trials

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
A
Comparison of the Efficacy and Safety of Continuous and Single-Dose Intravesical Epirubicin Instillation
Not yet recruiting
  • Bladder Cancer
  • +3 more
  • Intravesical Solution
  • Ankara, Altindag, Turkey
    Ankara Training and Research Hospital
2021-10-06
Oct 6, 2021
S
Outcome of Treating Bladder Cancer in Sohag University Hospital
Not yet recruiting
  • Bladder Cancer
  • Chemotherapy, Radiotherapy and surgery
  • (no location specified)
2021-10-15
Oct 15, 2021
U
CISTO: Comparison of Intravesical Therapy and Surgery as Treatment Options for Bladder Cancer
Recruiting
  • Bladder Cancer
  • +2 more
    • Birmingham, Alabama
    • +30 more
    2021-10-13
    Oct 13, 2021
    N
    Natural History of Urothelial Cancer and Rare Genitourinary Tract Malignancies
    Not yet recruiting
    • Urothelial Cancer
    • +4 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      2021-10-14
      Oct 14, 2021
      H
      A Study of Atezolizumab in Participants With Locally Advanced or Metastatic Urothelial Bladder Cancer (Cohort 1)
      Active, not recruiting
      Has Results
      • Bladder Cancer
      • Birmingham, Alabama
      • +76 more
      2021-09-21
      Sep 21, 2021
      D
      Sacituzumab Govitecan Plus EV in Metastatic UC
      Recruiting
      • Urothelial Cancer
      • +3 more
      • Sacituzumab Govitecan (SG)
      • Enfortumab vedotin-ejfv (EV)
      • Boston, Massachusetts
        Dana Farber Cancer Institute
      2021-10-14
      Oct 14, 2021
      U
      Study Comparing the Standard Administration of IO Versus the Same IO Administered Each 3 Months in Patients With Metastatic Cancer in Response After 6 Months of Standard IO
      Not yet recruiting
      • Lung Cancer Metastatic
      • +7 more
      • Reduced dose intensity of IO
      • Angers, France
      • +25 more
      2021-10-13
      Oct 13, 2021
      A
      Intravesical Prostatic Protrusion Mimicking Urothelial Cell Carcinoma of the Bladder: A Prospective Study
      Recruiting
      • Bladder Cancer
      • +2 more
      • Urethrocystoscopy
      • Ankara, Altindag, Turkey
        Ankara Training and Research Hospital
      2021-10-12
      Oct 12, 2021
      N
      Collection of Serum and Tissue Samples From Patients With Biopsy-Proved or Suspected Malignant Disease
      Recruiting
      • Malignant Neoplasms
      • +4 more
        • Bethesda, Maryland
          National Institutes of Health Clinical Center, 9000 Rockville Pi
        2021-10-13
        Oct 13, 2021
        S
        Behavioral Weight Loss Program for Cancer Survivors in Maryland
        Recruiting
        • Breast Cancer
        • +7 more
        • Written Weight Loss Material
        • +2 more
        • Baltimore, Maryland
          Johns Hopkins ProHealth
        2021-10-13
        Oct 13, 2021
        E
        Study of Seribantumab in Adult Patients With NRG1 Gene Fusion Positive Advanced Solid Tumors
        Recruiting
        • Locally Advanced Solid Tumor
        • +16 more
        • Birmingham, Alabama
        • +26 more
        2021-10-13
        Oct 13, 2021
        A
        Single-use Cystoscope System for Direct Visualization of the Urethra and Bladder - 2021
        Completed
        • Cystoscope
        • +2 more
        • Ambu aScope 4 Cysto and aView Urologia
        • Herlev, Denmark
          Herlev Hospital
        2021-10-13
        Oct 13, 2021
        G
        A Study of Autogene Cevumeran (RO7198457) as a Single Agent and in Combination With Atezolizumab in Participants With Locally Advanced or Metastatic Tumors
        Recruiting
        • Melanoma
        • +7 more
        • Scottsdale, Arizona
        • +37 more
        2021-10-10
        Oct 10, 2021
        F
        Analysis of Primary and Metastatic Tumors in Patients With Renal Cell Carcinoma and Urothelial Carcinoma
        Recruiting
        • Renal Cell Carcinoma
        • +4 more
        • Immune checkpoint inhibitor targeting PD1
        • Philadelphia, Pennsylvania
          Fox Chase Cancer Center - Philadelphia
        2021-10-11
        Oct 11, 2021
        U
        Trial to Compare Robotically Assisted Radical Cystectomy With Open Radical Cystectomy
        Active, not recruiting
        • Bladder Cancer
        • Intracorporeal Robot Assisted Radical Cystectomy
        • Open Radical Cystectomy
        • Bristol, United Kingdom
        • +7 more
        2021-10-11
        Oct 11, 2021
        N
        En-bloc Transurethral Resection of Bladder Tumor (En-bloc TURBT) Specimens Using a Redesigned Surgical Resectoscope Device
        Recruiting
        • Bladder Cancer
          • Bethesda, Maryland
            National Institutes of Health Clinical Center
          2021-10-09
          Oct 9, 2021
          P
          Pembrolizumab Monotherapy Following Tri-modality Treatment for Selected Patients With Muscle-invasive Bladder Cancer
          Not yet recruiting
          • Bladder Cancer
          • +4 more
          • Beijing, Beijing, China
            Peking University First Hospital
          2021-10-08
          Oct 8, 2021
          A
          A Study to Evaluate the Safety and Tolerability of Immunotherapy Combinations in Participants With Advanced Malignancies - 2021
          Completed
          • Non-small Cell Lung Cancer
          • +11 more
          • Scottsdale, Arizona
          • +14 more
          2021-10-07
          Oct 7, 2021
          N
          Naptumomab Estafenatox in Combination With Durvalumab in Subjects With Selected Advanced or Metastatic Solid Tumors
          Recruiting
          • ER+ Breast Cancer
          • +18 more
          • Obinutuzumab pretreatment (Gazyva®) Naptumomab estafenatox (ABR-217620; NAP) and durvalumab (IMFINZI; MEDI4736)
          • Naptumomab estafenatox (ABR-217620; NAP) and durvalumab (IMFINZI; MEDI4736)
          • Haifa, Israel
          • +3 more
          2021-10-03
          Oct 3, 2021
          T
          The Registry of Oncology Outcomes Associated With Testing and Treatment
          Recruiting
          • Adenocarcinoma
          • +75 more
          • Biomarker Testing (L)
          • +2 more
          • Idaho Falls, Idaho
            Teton Cancer Institute
          2021-10-04
          Oct 4, 2021
          L
          NY-ESO-1 Plasmid DNA (pPJV7611) Cancer Vaccine - 2007
          Completed
          Has Results
          • Prostate Cancer
          • +4 more
          • NY-ESO-1 Plasmid DNA Cancer Vaccine
          • New York, New York
          • +1 more
          2021-09-15
          Sep 15, 2021
          T
          Bladder Cancer Adjuvant Radiotherapy Trial
          Recruiting
          • Bladder Cancer
          • Urothelial Carcinoma Bladder
          • Adjuvant RT
          • Mumbai, Maharashtra, India
            Tata Memorial Centre
          2021-10-06
          Oct 6, 2021
          G
          My Pathway: A Study Evaluating Herceptin/Perjeta, Tarceva, Zelboraf/Cotellic, Erivedge, Alecensa, and Tecentriq Treatment Targeted Against Certain Molecular Alterations in Participants With Advanced Solid Tumors
          Active, not recruiting
          • Neoplasms
          • +4 more
          • Goodyear, Arizona
          • +60 more
          2021-10-06
          Oct 6, 2021
          G
          Trilaciclib, a CDK 4/6 Inhibitor, in Patients With Advanced/Metastatic Bladder Cancer Receiving Chemotherapy Then Avelumab
          Recruiting
          • Urothelial Carcinoma
          • +4 more
          • Whittier, California
          • +11 more
          2021-10-05
          Oct 5, 2021
          A
          The Effect of the COVID-19 Pandemic on Primary Bladder Cancer Presentations - 2021
          Completed
          • Bladder Cancer
          • Covid19
          • COVID-19 pandemic
          • Ankara, Altindag, Turkey
            Ankara Training and Research Hospital
          2021-09-29
          Sep 29, 2021